- Junior Mhlongo is the first South Africa to receive the trial vaccine which has been developed at the Oxford Jenner Institute
- He is one of 2 000 South Africans have joined in on the study to try and find a working vaccine against Covid-19
- He is eager to take part and wants the doctors to learn from him
Junior Mhlongo, 24, of Soweto has made history, he is the first South African citizen to receive the Covid-19 test vaccine as doctors roll out the experimental new preventative treatment.
2000 South Africans will join Junior in the study. He is excited and eager to help.
"I want to learn about the virus. I want doctors to be able to learn from me to help others."
“This is important. I am doing it to help. Not for any other reason,” he said, speaking moments after receiving an injection at an undisclosed Gauteng medical facility."
Shabir Madhi, professor of vaccinology at Wits University and director of the SA Medical Research Council's vaccines and infectious diseases analytics research unit, said it was an exciting moment."
“I won't lie, this has been keeping me up at night. It's the safety of this trial that is the most important thing.”
The Sowetan reported that 5 000 Brazilians, 4 000 British and a further 10 000 volunteers have joined the study based on the vaccine which has been developed at the Oxford Jenner Institute.
Earlier, Briefly.co.za reported that the first clinical trials for the Covid-19 virus in the country and in Africa as a whole will be kicking off this week.
The first participants in the trial will be vaccinated soon, according to the University of the Witwatersrand.
The South African Ox1Cov-19 Vaccine VIDA-Trial aims to find a vaccine that will prevent infection of the virus that causes Covid-19.
Enjoyed reading our story? Download BRIEFLY's news app on Google Play now and stay up-to-date with major South African news!